PLOS Review: Veterinarian-Pharmacist Collaboration

According to PLOS One (Kambayashi et al., 2026), a scoping review that searched databases through 30 August 2025 screened 239 records and included 16 studies to map veterinarian-pharmacist collaboration.

• 239 records were retrieved and screened, and 16 studies published between 2007 and 2024 met inclusion criteria, according to PLOS One (Kambayashi et al., 2026).
• Pharmacists' most frequently reported role was compounding and dispensing, identified in 10 of 16 studies (62.5%), as reported in PLOS One (Kambayashi et al., 2026).
• The review was published on July 31, 2026 and concluded: "Pharmacists are expanding their role in veterinary medicine, evolving from traditional dispensing functions to active contributors to clinical care and medication safety, " (Kambayashi et al., PLOS One, 2026).
• A recurrent barrier is the perceived "knowledge gap" about species-specific physiology, which limited clinical trust between veterinarians and pharmacists in multiple countries, according to PLOS One (Kambayashi et al., 2026).

This scoping review synthesized global evidence by searching PubMed, Web of Science, Cochrane, Ichushi-Web, and Google Scholar and completed its final search on 30 August 2025, according to PLOS One (Kambayashi et al., 2026).

According to PLOS One (Kambayashi et al., 2026), the authors identified 239 records, removed 58 duplicates, screened 181 records at title/abstract, assessed 47 full texts, and included 16 studies published from 2007 to 2024.

According to PLOS One (Kambayashi et al., 2026), studies were concentrated in the United States (n = 7), New Zealand (n = 3), and Japan (n = 3), and most used cross-sectional survey designs focused on compounding, drug information, and inventory roles.

Use targeted qualitative methods to convert perception-based evidence into practice-ready recommendations, because PLOS One (Kambayashi et al., 2026) found most studies relied on surveys and interviews rather than objective clinical outcomes.

• Design mixed-methods follow-ups that link perceptions to measurable outcomes, because the PLOS One review (Kambayashi et al., 2026) identified a lack of quantitative outcome studies assessing pharmacist impact.
• Prioritize cross-language document retrieval and translation, because the PLOS One review (Kambayashi et al., 2026) noted non-English contributions (Japan, n = 3) that offer distinct models.
• Focus early qualitative sampling on high-value settings such as university hospitals, zoos, and oncology centers, because PLOS One (Kambayashi et al., 2026) reports pharmacists are more readily accepted in specialized environments.

The PLOS One scoping review (Kambayashi et al., 2026) documents a small but actionable evidence base: 239 records screened, 16 included studies, and dominant roles in compounding (62.5%).

Researchers should prioritize cross-language qualitative synthesis and targeted fieldwork in specialty settings to convert perceptions into measurable outcomes, as recommended by PLOS One (Kambayashi et al., 2026).

If you need to accelerate thematic coding, translate non-English reports, or produce reproducible synthesis tables from interviews and surveys, use a platform that supports document ingestion, AI-assisted coding, and visualization.

To try these workflows yourself, Try Evidano for free.